# The potential benefits of transcranial magnetic stimulation combined with reminiscence therapy on cognitive function in patients with stroke

**Authors:** Roucao Dai, Fengshuang Wang

PMC · DOI: 10.1515/med-2025-1372 · Open Medicine · 2026-01-13

## TL;DR

Combining transcranial magnetic stimulation with reminiscence therapy may improve cognitive function and independence in stroke patients.

## Contribution

This study demonstrates that combining TMS with reminiscence therapy improves cognitive outcomes in stroke patients.

## Key findings

- Patients receiving TMS plus reminiscence therapy had significantly higher MMSE and MoCA scores.
- The combination therapy led to shorter Trail Making Test times and higher FIM scores.
- No significant adverse events were associated with the combined therapy.

## Abstract

Stroke is a major cause of long-term disability and cognitive impairment, substantially affecting patients’ quality of life and functional independence. Effective strategies for post-stroke cognitive recovery remain limited. To evaluate the effects of transcranial magnetic stimulation (TMS) combined with reminiscence therapy on cognitive function and functional independence in stroke patients.

A retrospective cohort study was conducted at a rehabilitation hospital from March 2017 to October 2024, including patients with ischemic stroke and cognitive impairment who received either routine treatment (n=68) or TMS combined with reminiscence therapy (n=66). Cognitive and functional outcomes were assessed using the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Trail Making Test (TMT), and Functional Independence Measure (FIM).

Post-treatment, the TMS plus reminiscence therapy group showed significantly higher MMSE (27.42 ± 3.08 vs. 25.18 ± 3.41, p=0.0001) and MoCA scores (20.05 ± 3.99 vs. 18.44 ± 4.05, p=0.0020), and shorter TMT times (65.28 ± 9.75 vs. 72.45 ± 10.32, p<0.001). FIM scores were also higher (92.18 ± 7.06 vs. 88.35 ± 7.15, p=0.0024). No significant differences in adverse events were observed.

TMS combined with reminiscence therapy may effectively enhance cognitive function and functional independence in patients with post-stroke cognitive impairment.

## Linked entities

- **Diseases:** stroke (MONDO:0005098)

## Full-text entities

- **Genes:** TPSG1 (tryptase gamma 1) [NCBI Gene 25823] {aka PRSS31, TMT, trpA}
- **Diseases:** brain tumors (MESH:D001932), Cognitive deficits (MESH:D003072), seizure (MESH:D012640), dementia (MESH:D003704), Stroke (MESH:D020521), depression (MESH:D003866), hemorrhagic (MESH:D006470), scalp discomfort (MESH:D004476), anxiety (MESH:D001007), brain trauma (MESH:D000070642), cerebral infarction (MESH:D002544), diabetes (MESH:D003920), post (MESH:D000094025), muscle twitching (MESH:D019042), hypertension (MESH:D006973), hyperlipidemia (MESH:D006949), headache (MESH:D006261)
- **Chemicals:** YK-2022-01-012 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12917588/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12917588/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12917588/full.md

---
Source: https://tomesphere.com/paper/PMC12917588